Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Ondine Biomed (OBI)

Price 6.50p on 09-10-2024 at 12:17:40
Change 0.125p 1.96%
Buy 6.75p
Sell 6.25p
Buy / Sell OBI Shares
Last Trade: Sell 5,420.00 at 6.42p
Day's Volume: 30,640
Last Close: 6.375p
Open: 6.375p
ISIN: CA68234M2058
Day's Range 6.25p - 6.50p
52wk Range: 5.125p - 15.50p
Market Capitalisation: £18m
VWAP: 6.277828p
Shares in Issue: 277m

Listed In: FTSE AIM All-Share,

Recent Trades History Ondine Biomed (OBI)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 5,420 6.42p Ordinary
13:17:39 - 09-Oct-24
Sell* 24,945 6.25p Uncrossing Trade
11:00:29 - 09-Oct-24
Sell* 275 6.00p SI Trade
08:00:04 - 09-Oct-24

Share Price History for Ondine Biomed

Time period:
to
Date Open High Low Close Volume

Share News for Ondine Biomed

EARNINGS: Katoro Gold pretax loss narrows; Ondine Biomedical sales up

30th Sep 2024 13:43

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Ondine Biomedical inks research deal for Steriwave ICU use

25th Sep 2024 14:30

Ondine Biomedical Inc - Vancouver-based company specialising in photodisinfection-based therapies - Announces research collaboration with the Royal Columbian Hospital Foundation's Advancing Innovation in Medicine division. RCH Foundation is an independent charitable organisation that funds priority equipment, major projects and other RCH needs. Says research collaboration is in support of Steriwave use in intensive care units, and is investigating Steriwave's impact on infection prevention and patient outcomes in critical care settings starting with a 320-patient pilot. Ondine says there is potential for a subsequent multicentre trial with up to 2,000 patients depending on pilot results. Read More

IN BRIEF: Ondine Biomedical secures CAD5 million financing

24th Sep 2024 16:20

Ondine Biomedical Inc - Vancouver-based company specialising in photodisinfection-based therapies to prevent and treat a broad spectrum of infections - Announces it has agreed to private placement financing in exchange for common shares from a third-party private investor in Canada to support commercial growth. Ondine will issue 22.2 million new common shares, raising CAD5 million - around GBP2.8 million - at 12.5 pence per share. Read More

AIM WINNERS & LOSERS: Itim boosts revenue, Clontarf raises GBP450,000

24th Sep 2024 10:36

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

IN BRIEF: Ondine says Steriwave use spreads across British Columbia

23rd Aug 2024 19:33

Ondine Biomedical Inc - Vancouver-based company specialising in photodisinfection-based therapies to prevent and treat a broad spectrum of infections - Says Steriwave nasal decolonization is now being used in all five of British Columbia's health authorities. Feels this signals Ondine's increasingly "strong presence" across the Canadian healthcare system. Read More

FTSE 100 Latest
Value8,207.25
Change16.64

Login to your account

Forgot Password?

Not Registered